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background: Redo heart transplantation (rHT) poses an ethical issue given the scarcity of donors. We sought to investigate long-term outcomes by 
era performed at a busy US center that has performed greater than 2000 heart transplants (HT).
Methods: 1378 HT & 95 rHT pts were identified(1987-2012) & stratified by era (1: 1987-2001 [732 HT; 49 rHT] & 2: 2002-2012 [648 HT; 46 
rHT]). Exclusions included: rHT>1 & follow-up (FU) loss. Survival was censored at 12y & multivariate Cox proportional hazard regression models were 
adjusted for age, sex, diabetes, race, ischemic time, dialysis, etiology, life support, wait time & HLA mismatch.
results: Mean age was 47y ± 20. Amongst rHT pts, transplant vasculopathy was the most prevalent indication (79%) whereas dilated (43%) and 
ischemic cardiomyopathy (40%) was most prevalent for first-time HT. FU began at time of first HT (mean 72 ± 63 months). 751 pts died (50% HT & 
58% rHT, p=0.16). Crude survival is shown (Figure). Unadjusted HR for all-cause mortality (rHT vs HT) was 1.52 (CI 1.15-2.02). Multivariate analysis 
yielded a hazard ratio of 1.56 (CI 1.10 to 2.21). Comparing HT, era 2 vs. era 1: [era 2 [0.66 (0.55-0.79)]. Comparing rHT, era 2 vs. era 1: [0.45 
(0.25-0.81)]. After adjustment: HT [era 2 vs 1 [0.66 (0.55-0.79)] and rHT: era 2 vs era1: [0.44 (0.24-0.80).
conclusions: In selected patients, rHT can be performed with comparable short and long-term outcomes as first-time heart transplantation. 
Offering redo heart transplantation to selected patients is warranted.
 
